TLDR:
- Two Bear Capital has expanded its team of experts with five key executive appointments.
- The firm aims to support innovative founders and build a top-tier venture capital firm.
Two Bear Capital, a venture capital firm focusing on disruptors in life sciences and technology, has announced the addition of key executives to their team during a period of rapid growth. The new appointments include:
Bridget Martell MA, MD as Operating Partner, Biotechnology, who will focus on biopharma and health tech portfolio companies. Jeff Miller joins as Operating Partner, Enterprise, to work with the enterprise portfolio companies. Tim Veil has been appointed as Principal, to identify new technology-focused investments. Kevin Day and Jennifer Howrigan have been added to the fundraising and investor relations team.
Two Bear Capital aims to deliver deep domain expertise to help portfolio companies grow and succeed in bringing breakthrough products to market. The firm also seeks to enhance its fundraising efforts as it pursues new opportunities and builds a long-lasting, top-tier venture capital firm. The executives bring a wealth of experience and strategic thinking to the firm, positioning Two Bear Capital for continued success in supporting innovative founders.
Each executive brings a unique background to the team, with experience in companies ranging from pharma and biotech to software and deep tech. With a focus on early founder-led companies with disruptive innovations, Two Bear Capital is set to continue its mission of building enduring high-impact businesses that benefit society as a whole.
